Finance

Beta
Lists
347740:KOSDAQ
P&K Skin Research Center Co Ltd
₩1,892.00
-0.79%
(-15.00) 1D
Jun 10, 3:30:08 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 347740...
Open
₩1,821
High
₩1,900
Low
₩1,821
Mkt. cap
56.78B
Avg. vol.
113.71K
Volume
29.93K
Dividend
2.64%
Quarterly dividend
₩13
Ex-dividend date
Dec 27, 2023
P/E ratio
14.32
52-wk high
₩3,300
52-wk low
₩1,810
EPS
₩132
Shares outstanding
30.01M
No. of employees
122
Open
₩1,821
High
₩1,900
Low
₩1,821
Mkt. cap
56.78B
Avg. vol.
113.71K
Volume
29.93K
Dividend
2.64%
Quarterly dividend
₩13
Ex-dividend date
Dec 27, 2023
P/E ratio
14.32
52-wk high
₩3,300
52-wk low
₩1,810
EPS
₩132
Shares outstanding
30.01M
No. of employees
122
News stories
From sources across the web
About P&K Skin Research Center Co Ltd
CEO-
Employees122
Founded2010
Headquarters-
SectorHealth care
Websitepnkskin.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.49B
5.05B
5.78B
6.24B
Cost of goods sold
3.08B
2.94B
3.03B
3.27B
Cost of revenue
3.08B
2.94B
3.03B
3.27B
Research and development expenses
376.79M
386.70M
482.62M
394.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.11B
1.15B
1.36B
1.44B
Operating expense
1.59B
1.66B
2.00B
2.01B
Total operating expenses
4.66B
4.60B
5.03B
5.28B
Operating income
825.00M
451.77M
752.45M
958.56M
Other non operating income
-13.15M
-14.90M
-306.87M
796.77M
EBT including unusual items
1.91B
1.88B
-896.89M
1.75B
EBT excluding unusual items
1.44B
1.36B
1.02B
1.76B
Income tax expense
304.20M
305.32M
9.25M
293.74M
Effective tax rate
15.90%
16.25%
-1.03%
16.74%
Other operating expenses
5.42M
7.15M
5.32M
55.55M
Net income
1.61B
1.59B
-876.93M
1.49B
Net profit margin
29.38%
31.54%
-15.17%
23.83%
Earnings per share
-
-
-
-
Interest and investment income
648.33M
933.82M
586.17M
-
Interest expense
-15.08M
-13.49M
-14.03M
-
Net interest expenses
633.24M
920.32M
572.14M
-
Depreciation and amortization charges
112.47M
110.98M
108.40M
105.66M
EBITDA
1.33B
980.70M
1.28B
1.46B
Gain or loss from assets sale
-
992.22K
-6.58M
1.06M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer